You are here > Services > Research and Development > Our current areas of Research > Cancer Studies > Haematology Cancer Studies

Haematology Cancer Studies


A Randomised Investigation of Alternative Ofatumumab containing regimens in less fit patient with CLL.

Study Area: Haematology

Aim: A study for less fit or older patients with a new diagnosis of CCL, comparing ofatumumab + bendamustine with ofatumumab + chlorambucil to see which is most effective. Six cycles of chemotherapy and three monthly regular follow ups checking blood results and side effects.

Who can Participate: confirmed new diagnosis of chronic lynmhocycic leukaemia age 75 or older and/or other health problems such as heart issues or COPD.

If you would like any further information on the following studies, and to find out if you are eligible please contact:


Address: R&D office, C254, West Wing, Broomfield Hospital, Court Road, Chelmsford, Essex, CM1 7ET

Telephone: 01245 515136
Email: Research@meht.nhs.uk